MedConclusion: A Benchmark for Biomedical Conclusion Generation from Structured Abstracts
Abstract
Large language models (LLMs) are widely explored for reasoning-intensive research tasks, yet resources for testing whether they can infer scientific conclusions from structured biomedical evidence remain limited. We introduce , a large-scale dataset of PubMed structured abstracts for biomedical conclusion generation. Each instance pairs the non-conclusion sections of an abstract with the original author-written conclusion, providing naturally occurring supervision for evidence-to-conclusion reasoning. MedConclusion also includes journal-level metadata such as biomedical category and SJR, enabling subgroup analysis across biomedical domains. As an initial study, we evaluate diverse LLMs under conclusion and summary prompting settings and score outputs with both reference-based metrics and LLM-as-a-judge. We find that conclusion writing is behaviorally distinct from summary writing, strong models remain closely clustered under current automatic metrics, and judge identity can substantially shift absolute scores. MedConclusion provides a reusable data resource for studying scientific evidence-to-conclusion reasoning. Our code and data are available at: https://github.com/Harvard-AI-and-Robotics-Lab/MedConclusion.
Figures & tables
| Dataset | Study Design | ||||||
| Name | Data Size | Broad Biomed. | Struc. Abs. | Gold References | Journal Metadata | Summary Contrast | Judge Robust. |
| Gao et al. (2024) | 17.4K | ✓ | ✓ | ✓ | ✗ | ✗ | ✗ |
| Shieh et al. (2019) | 195.7K | ✗ | ✓ | ✓ | ✗ | ✗ | ✗ |
| Tang et al. (2022) | 57.1K | ✗ | ✗ | ✓ | ✗ | ✗ | ✗ |
| Tang et al. (2023) | 200.2K | ✗ | ✗ | ✓ | ✗ | ✗ | ✗ |
| Bastan et al. (2022) | 633K | ✓ | ✗ | ✓ | ✗ | ✗ | ✗ |
| Model | Semantic Sim. | Writing Style Sim. | Non-Contradiction Rate | Numeric Consistency | Formality Sim. |
| General-purpose Models | |||||
| GPT-5.4 | 73.22 | 71.21 | 84.61 | 88.24 | 89.80 |
| Gemini 3.1 Pro | 71.87 | 70.13 | 82.02 | 86.92 | 89.49 |
| Gemini 3 Flash | 71.33 | 69.87 | 81.76 | 86.45 | 89.17 |
| Gemma-3-27B | 71.03 | 69.18 | 81.55 | 84.13 | 89.36 |
| DeepSeek-V3.2 | 69.47 | 68.21 | 80.31 | 86.22 | 88.59 |
| Model | WC Ratio | SC Ratio | Embed. Sim. | ROUGE- 1 | ROUGE- 2 | ROUGE- L | BLEU | PPL Orig. | PPL Gen. |
| General-purpose Models | |||||||||
| GPT-5.4 | 2.19 | 1.71 | 0.77 | 0.34 | 0.10 | 0.21 | 0.04 | 70.26 | 40.39 |
| Gemini 3.1 Pro | 2.28 | 1.75 | 0.73 | 0.33 | 0.10 | 0.21 | 0.04 | 70.26 | 34.54 |
| Gemini 3 Flash | 2.12 | 1.69 | 0.74 | 0.34 | 0.10 | 0.21 | 0.04 | 70.26 | 33.87 |
| Gemma-3-27B | 2.49 | 2.01 | 0.77 | 0.32 | 0.09 | 0.20 | 0.04 | 70.26 | 30.46 |
| DeepSeek-V3.2 | 1.73 | 1.38 | 0.76 | 0.35 | 0.11 | 0.23 | 0.05 | 70.26 | 47.14 |
| Mode | Model | Semantic Sim. | Writing Style Sim. | Non-Contradiction Rate | Numeric Consistency | Formality Sim. |
| Prompt without Formatting Restriction | ||||||
| {tikzpicture} [baseline=(char.base)] \node [shape=circle, draw, inner sep=0.5pt, fill=black, text=white, font= ] (char) A; | GPT-5.4 | 73.22 | 71.20 | 84.61 | 88.24 | 89.80 |
| Gemini 3 Flash | 71.33 | 69.87 | 81.76 | 86.45 | 89.17 | |
| {tikzpicture} [baseline=(char.base)] \node [shape=circle, draw, inner sep=0.5pt, fill=black, text=white, font= ] (char) B; | GPT-5.4 | 72.11 | 62.60 | 83.96 | 66.24 | 88.47 |
| Gemini 3 Flash | 71.04 | 61.55 | 82.44 | 58.09 | 88.11 | |
| Prompt with Length and Writing Style Restriction | ||||||
| Model | Semantic Sim. | Writing Style Sim. | Non-Contradiction Rate | Numeric Consistency | Formality Sim. |
| Judge: GPT-5.4-mini | |||||
| GPT-5.4 | 73.22 | 71.20 | 84.61 | 88.24 | 89.80 |
| Gemini 3.1 Pro | 71.87 | 70.13 | 82.02 | 86.92 | 89.49 |
| Gemini 3 Flash | 71.33 | 69.87 | 81.76 | 86.45 | 89.17 |
| Judge: Gemini 3 Flash | |||||
| GPT-5.4 | 84.30 | 71.49 | 97.51 | 98.18 | 92.50 |
Appendix figures & tables20 assets
Supplementary material from the paper’s appendix.
Appendix
| Category | Semantic Sim. | Writing Style | Non-Contrad. Rate | Numeric Cons. | Formality Sim. |
| Immunology & Microbiology | |||||
| Pharm., Toxicology & Pharmaceutics | |||||
| Exp. & Cognitive Psychology | |||||
| Arts & Humanities | |||||
| Virology | |||||
| Nursing |
| Category | Semantic Sim. | Writing Style | Non-Contrad. Rate | Numeric Cons. | Formality Sim. |
| Cancer Research | |||||
| Organic Chemistry | |||||
| Endocrinology, Diabetes & Metab. | |||||
| Cellular & Mol. Neuroscience | |||||
| Hepatology | |||||
| Biochemistry |
| Short Name | Full Name | Access | Capability | Scale | Max New Tokens | Temp. |
| General-purpose Models | ||||||
| GPT-5.4 | gpt-5.4 ( OpenAI, 2026 ) | Proprietary | General-purpose | Large | 1024 | 0 |
| Gemini 3.1 Pro | gemini-3.1-pro ( Google DeepMind, 2026 ) | Proprietary | General-purpose | Large | 1024 | 0 |
| Gemini 3 Flash | gemini-3-flash ( Google DeepMind, 2025 ) | Proprietary | General-purpose | Medium | 1024 | 0 |
| DeepSeek-V3.2 | DeepSeek-V3.2 ( DeepSeek-AI, 2025b ) | Proprietary | General-purpose | Large | 1024 | 0 |
| MiniMax-M2.1 | MiniMax-M2.1 ( MiniMax, 2025 ) | Proprietary | General-purpose | Large | 1024 | 0 |
Evidence-Grounded Generation
Evidence-grounded generation produces answers and documents whose claims are supported by traceable sources.
See all 148 papers